Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment
Российский кардиологический журнал, 2007 The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups.
G. G. Semenkova, L. V. Kokoreva
doaj +2 more sources
Российский кардиологический журнал, 2005 This article is focused on myocardial cytoprotectors - mildronate and trimethazidine (Preductal MB) - influence on free-radical myocardial processes in stable angina patients before and after transluminal coronary angioplasty and coronary stenting ...
I. G. Gordeev +6 more
doaj +2 more sources
PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE [PDF]
Рациональная фармакотерапия в кардиологии, 2015 Issues of pathogenesis of the calcified aortic stenosis and ischemic heart disease in the elderly are considered. The relevance of early detection of angina, syncope, and dyspnea in view of their non-specific and subclinical course for early detection of
N. Yu. Karpova +4 more
doaj +4 more sources
METABOLIC MYOCARDIAL CYTOPROTECTORS IN THERAPY OF STABLE ISCHEMIC HEART DISEASE: EVIDENCE OF EFFECTIVENESS AND USE RECOMMENDATIONS [PDF]
Медицинский совет, 2017 The review describes mechanisms of action of metabolic myocardial cytoprotectors and recommendations on their use within the pharmacotherapy of stable ischemic heart disease.
N. B. Perepech
doaj +2 more sources
COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
Российский кардиологический журнал, 2009 The molecular effects of trimetazidine and mildronate were investigated in patients with stable effort angina, Functional Class (FC) I-III. The comparison criteria included blood activity and concentrations of the main products of free-radical oxidation ...
E. A. Kartashova
doaj +2 more sources
Chronic heart failure: prevention and treatment options
Медицинский совет, 2013 The problem of chronic heart failure remains relevant today. According to the Age of CHF study, the prevalence of this disease in this country is 12%. In 66% of cases CHF has ischemic etiology.
S. B. Migutina
doaj +2 more sources
Arquivos de Gastroenterologia, 2009 CONTEXT: Exposure of hepatocytes to pathological conditions in a microenvironment of hypoxia and reoxygenation is very frequent in hepatic diseases.
Dahir Ramos de Andrade Jr. +2 more
doaj +2 more sources
Molecular mechanisms of neuroprotective effects of thyroid hormones and their metabolites in acute brain ischemia [PDF]
Анналы клинической и экспериментальной неврологии, 2023 As endovascular reperfusion advances and multimodal neuroimagimg is implemented, neuroprotection in ischemic stroke progresses to the next level. In the recent years, the focus of neuroprotection research has been gradually shifting towards the research ...
Dmitry A. Filimonov +2 more
doaj +3 more sources
ЦИТОПРОТЕКЦИЯ В КАРДИОЛОГИИ: ДОСТИГНУТЫЕ УСПЕХИ И ПЕРСПЕКТИВЫ. Часть 2 [PDF]
Архивъ внутренней медицины, 2014 The article is devoted to a new direction in medical treatment of ischemic heart disease and arterial hypertension — the use of cytoprotective and antioxidant agents. The intracellular mechanisms of development of hypoxia and ischemia, fabrics, oxidative
В. П. Михин
doaj +2 more sources
Potential use of methylmethionine sulfonium chloride as a component of combination therapy for peptic ulcer and gastroduodenitis [PDF]
Медицинский совет, 2018 It is known that gastritis, gastroduodenitis and peptic ulcer belong to the group of acid-dependent diseases, which occupy a significant proportion among the digestive system diseases.
I. G. Pakhomova
doaj +2 more sources